Amsler K - Search Results

1

Parallel synthesis of potent, pyrazole-based inhibitors of Helicobacter pylori dihydroorotate dehydrogenase.

Haque TS, Tadesse S, Marcinkeviciene J, Rogers MJ, Sizemore C, Kopcho LM, Amsler K, Ecret LD, Zhan DL, Hobbs F, Slee A, Trainor GL, Stern AM, Copeland RA, Combs AP. Haque TS, et al. Among authors: amsler k. J Med Chem. 2002 Oct 10;45(21):4669-78. doi: 10.1021/jm020112w. J Med Chem. 2002. PMID: 12361393

2

Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model.

Sizemore CF, Quispe JD, Amsler KM, Modzelewski TC, Merrill JJ, Stevenson DA, Foster LA, Slee AM. Sizemore CF, et al. Antimicrob Agents Chemother. 2002 May;46(5):1435-40. doi: 10.1128/AAC.46.5.1435-1440.2002. Antimicrob Agents Chemother. 2002. PMID: 11959579 Free PMC article.

3

Glutamyl-gamma-boronate inhibitors of bacterial Glu-tRNA(Gln) amidotransferase.

Decicco CP, Nelson DJ, Luo Y, Shen L, Horiuchi KY, Amsler KM, Foster LA, Spitz SM, Merrill JJ, Sizemore CF, Rogers KC, Copeland RA, Harpel MR. Decicco CP, et al. Among authors: amsler km. Bioorg Med Chem Lett. 2001 Sep 17;11(18):2561-4. doi: 10.1016/s0960-894x(01)00499-1. Bioorg Med Chem Lett. 2001. PMID: 11549469

4

Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

Fernandez J, Abbanat D, Shang W, He W, Amsler K, Hastings J, Queenan AM, Melton JL, Barron AM, Flamm RK, Lynch AS. Fernandez J, et al. Among authors: amsler k. Antimicrob Agents Chemother. 2012 Mar;56(3):1476-84. doi: 10.1128/AAC.06057-11. Epub 2012 Jan 9. Antimicrob Agents Chemother. 2012. PMID: 22232278 Free PMC article.

5

A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.

Nicholson SC, Welte T, File TM Jr, Strauss RS, Michiels B, Kaul P, Balis D, Arbit D, Amsler K, Noel GJ. Nicholson SC, et al. Among authors: amsler k. Int J Antimicrob Agents. 2012 Mar;39(3):240-6. doi: 10.1016/j.ijantimicag.2011.11.005. Epub 2012 Jan 9. Int J Antimicrob Agents. 2012. PMID: 22230331 Clinical Trial.

6

Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.

Noel GJ, Strauss RS, Amsler K, Heep M, Pypstra R, Solomkin JS. Noel GJ, et al. Among authors: amsler k. Antimicrob Agents Chemother. 2008 Jan;52(1):37-44. doi: 10.1128/AAC.00551-07. Epub 2007 Oct 22. Antimicrob Agents Chemother. 2008. PMID: 17954698 Free PMC article. Clinical Trial.

7

In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.

Amsler KM, Davies TA, Shang W, Jacobs MR, Bush K. Amsler KM, et al. Antimicrob Agents Chemother. 2008 Sep;52(9):3418-23. doi: 10.1128/AAC.00336-08. Epub 2008 Jun 30. Antimicrob Agents Chemother. 2008. PMID: 18591277 Free PMC article. Clinical Trial.

8

Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against gram-negative and gram-positive pathogens.

Amsler K, Santoro C, Foleno B, Bush K, Flamm R. Amsler K, et al. J Clin Microbiol. 2010 Sep;48(9):3353-7. doi: 10.1128/JCM.00494-10. Epub 2010 Jun 30. J Clin Microbiol. 2010. PMID: 20592149 Free PMC article.

9

Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine.

Abbanat D, Davies TA, Amsler K, He W, Fae K, Janssen S, Poolman JT, van den Dobbelsteen GPJM. Abbanat D, et al. Among authors: amsler k. Clin Vaccine Immunol. 2017 Dec 5;24(12):e00123-17. doi: 10.1128/CVI.00123-17. Print 2017 Dec. Clin Vaccine Immunol. 2017. PMID: 28971965 Free PMC article.

10

Molecular characterisation of meticillin-resistant Staphylococcus aureus isolates from two ceftobiprole Phase 3 complicated skin and skin-structure infection clinical trials.

Davies TA, Shang W, Amsler KM, Bajaksouzian S, Jacobs MR, Bush K. Davies TA, et al. Among authors: amsler km. Int J Antimicrob Agents. 2009 Aug;34(2):166-8. doi: 10.1016/j.ijantimicag.2009.02.013. Epub 2009 Apr 2. Int J Antimicrob Agents. 2009. PMID: 19345071 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters